Press Release
Category Added in a WPeMatico Campaign
-
Business Wire2 weeks ago
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$IBRX—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against…
Read More » -
Business Wire2 weeks ago
WMK Investors Have Opportunity to Join Weis Markets, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$WMK—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Read More » -
Business Wire2 weeks ago
EVTL Investors Have Opportunity to Join Vertical Aerospace Ltd. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$EVTL—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Read More » -
Business Wire2 weeks ago
SAN Investors Have Opportunity to Join Banco Santander, S.A. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$SAN—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Read More » -
Business Wire2 weeks ago
BW Investors Have Opportunity to Join Babcock & Wilcox Enterprises, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$BW—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Read More » -
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention VESALIUS-CV…
Read More » -
Business Wire2 weeks ago
Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously Published in JACC
Patients treated with tonlamarsen experienced statistically significant reductions in plasma angiotensinogen levels and clinically meaningful changes in systolic blood pressure…
Read More » -
Business Wire2 weeks ago
Debevoise Secures Second Circuit Affirmance of Dismissal of $16 billion Claim Against YPF S.A.
NEW YORK–(BUSINESS WIRE)–Debevoise & Plimpton LLP has secured affirmance from the U.S. Court of Appeals for the Second Circuit of…
Read More » -
Business Wire2 weeks ago
YRD Investors Have Opportunity to Join Yiren Digital Ltd. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$YRD—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Read More » -
Business Wire2 weeks ago
PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$PODD—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Read More »
